This article has Open Peer Review reports available.
Malignant peritoneal mesothelioma presenting as recurrent adhesion obstruction in general surgery: a case report
© Naraynsingh et al; licensee BioMed Central Ltd. 2011
Received: 13 July 2010
Accepted: 30 August 2011
Published: 30 August 2011
Malignant peritoneal mesothelioma is a well-described entity in many reports in the literature in which it has been associated with asbestosis. However, there is no information describing the gross appearance and cardinal features seen during laparotomy, hence it is easy for the unwary surgeon to miss the diagnosis of this rare condition.
A 49-year-old man of African descent presented to our hospital with a three-month history of weight loss, anorexia, abdominal distension, and general signs of cachexia and ascites on second presentation. At first presentation one year prior to this, he had undergone a laparotomy at our institution by a different team for intestinal obstruction secondary to adhesions with no biopsy taken. The patient's condition subsequently progressively deteriorated, and investigations including upper and lower gastrointestinal endoscopies and computed tomography of the abdomen were inconclusive, except for some free fluid in the peritoneal cavity and diffuse, mild thickening of the gut wall and mesentery. A second-look exploratory laparotomy revealed widespread nodular thickening of the visceral peritoneum with a striking, uniformly diffuse, erythematous, and velvety appearance. The peritoneal biopsy histology showed that the patient had malignant peritoneal mesothelioma. His condition deteriorated rapidly, and he died eight weeks after surgery.
Our report aims to increase the diagnosing clinician's awareness of the cardinal features of malignant peritoneal mesothelioma and thus reduce diagnostic errors and delays in treatment.
We present the case of a 49-year-old man with asbestos exposure to illustrate the rarity and difficulty of the diagnosis of malignant peritoneal mesothelioma (MPM). This case report focuses on the clinical appearance of the condition during exploratory laparotomy and demonstrates the striking, uniformly diffuse, erythematous, and velvety aspect of the tumor as it infiltrates the peritoneal surface. This presentation has not been described previously in the literature, and we hope that this information assists clinicians and surgeons in recognizing the condition, should they confront it in the future.
At first presentation, a 49-year-old man of African descent who was a non-smoker presented with sudden onset of vomiting and abdominal distension. A clinical diagnosis of small-bowel obstruction was made based on presentation and plain abdominal radiographs. The patient underwent an exploratory laparotomy and a diagnosis of adhesions without obvious obstruction was diagnosed, but no biopsy taken.
MPM is a rare condition resulting most commonly from exposure to asbestos. The neoplasm manifests approximately 20 or more years after the initial exposure . Pathologically, patients present with tumors of the pleura (pulmonary) and peritoneum and, less frequently, the pericardium and the tunica vaginalis . Owing to the rarity and aggressive nature of this disease, the correct diagnosis is often delayed and treatment is frequently palliative.
MPM accounts for 20% to 33% of mesotheliomas, and histologically these may be divided into three basic forms: epithelioid (most common), sarcomatoid, and biphasic (mixed). Papillary peritoneal mesothelioma is a subdivision of the epithelioid form .
Clinically, this condition may be associated with abdominal pain, abdominal distension, ascites, weight loss, and pyrexia of unknown origin . The latter is a rare presentation. Upon consideration of MPM in the differential diagnosis, the medical practitioner should proceed with the following investigations. A plain chest radiograph may show signs of asbestos in the lung: small opacities in the lower lung fields with or without pleural thickening or effusion, indicative of pleural mesothelioma . An abdominal CT scan examination may show the presence of ascitic fluid and peritoneal thickening , and calretinin immunostaining of ascitic fluid can be done. This procedure has significantly increased the accuracy of the diagnosis .
At laparotomy, gross examination of the peritoneum may also reveal signs of the condition. Widespread nodular thickening of the visceral peritoneum with a striking, diffusely uniform, erythematous appearance (Figures 2 and 3) can be confirmed to be MPM on the basis of biopsy and histological examination. Grossly, peritoneal carcinomatosis can be confused with MPM. However, in carcinoma, the nodules vary considerably in size and the intervening areas are essentially normal (not uniformly erythematous). Peritoneal tuberculosis may also be confused with MPM, but in peritoneal tuberculosis the lesions are white with surrounding erythema and normal-appearing intervening serosa. In adhesions, the bands are obvious and the bowel serosa is normal.
In the case of our patient, the first surgeon unknowingly diagnosed adhesions without entertaining the diagnosis of MPM, probably because MPM is so rare that few surgeons would have suspected it. Therefore, no biopsies were taken during the first laparotomy.
Thus, if there is widespread nodular thickening of both parietal and visceral peritoneum with marked uniformly diffuse erythema and ascites, MPM should be suspected and a biopsy should be performed. Moreover, since exposure to asbestos often occurs many years before its effects manifest as overt disease, the patient does not usually reveal it while the history is being recorded unless specifically asked.
Once the diagnosis is confirmed by histology, multi-disciplinary management produces the best outcome . The prognosis for patients with MPM is poor, with a survival time of approximately two years from diagnosis. Despite this poor prognosis, a potential cure has been described in the literature, the emphasis of which is early diagnosis coupled with definitive local and regional treatment.
Treatment options include operative cytoreduction, followed by heated intra-peritoneal chemotherapy applied intra-operatively with doxorubicin and cisplastin . Early postoperative adjuvant therapy with paclitaxel is also initiated. The efficacy of these interventions are assessed during second-look cytoreduction surgery . A recent paper by Husain et al.  highlights the fact that MPM is a rare tumor that is difficult to diagnose and provides guidelines for pathologists.
This case report is important to public health, since it deals with the detection and diagnosis of MMP, which is a very important public health issue. It illustrates the vague clinical presentation of MPM, where the difficulty in diagnosis is a result of the rarity of this disease. Despite this fact, our patient presented with the most common symptoms of this condition. On the basis of the patient's history, occupational exposure to asbestos was a critical factor in the diagnosis. Furthermore, if the surgeon who performed the first laparotomy one year prior to the patient's second presentation had diagnosed MPM based on the appearance and examination of the peritoneum, this would have played a crucial role in early detection of the disease.
Consequently, we wish to highlight the clinical gross appearance of this rare condition for the unwary clinician as widespread fine nodular thickening of the visceral peritoneum with a striking, uniformly diffuse, erythematous, and velvety appearance. In contrast, other considerations in the differential diagnosis of this condition could be as follows: tuberculosis may present as ileocecal inflammation, carcinomatosis appears as hard white nodules with the intervening peritoneum having a normal appearance, and endometriosis of the peritoneum and/or omentum, characterized by hemorrhagic, reddish brown, or blue nodules or cysts on the peritoneal surface .
Written informed consent for publication from the patient's next of kin could not be obtained despite all reasonable attempts. The case is important to public health and every effort has been made to protect the identity of our patient. There is no reason to believe that our patient would object to publication
- Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ: Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med. 1988, 45: 182-187.PubMedPubMed CentralGoogle Scholar
- Bridda A, Padoan I, Mencarelli R, Frego M: Peritoneal mesothelioma: a review. MedGenMed. 2007, 9: 32-PubMedPubMed CentralGoogle Scholar
- Tejido García R, Anta Fernández M, Hernández Hernández JL, Bravo González J, Macías J: [Fever of unknown origin as the clinical presentation of malignant peritoneal mesothelioma] [in Spanish]. An Med Interna. 1997, 14: 573-575.PubMedGoogle Scholar
- Lautenschläger M: [Asbestosis accompanied by primary peritoneal mesothelioma] [in German]. Radiologe. 1992, 32: 83-86.Google Scholar
- Sinan T, Sheikh M, Ramadan S, Sahwney S, Behbehani A: CT features in abdominal tuberculosis: 20 years experience. BMC Med Imaging. 2002, 2: 3-10.1186/1471-2342-2-3.View ArticlePubMedPubMed CentralGoogle Scholar
- Hirano H, Fujisawa T, Maekawa K, Ohkubo E, Okimura A, Kuribayashi K, Nakano T, Nakasho K, Nishigami T: Malignant mesothelioma of the peritoneum: case reports and immunohistochemical findings including Ki-67 expression. Med Mol Morphol. 2010, 43: 53-59. 10.1007/s00795-009-0460-0.View ArticlePubMedGoogle Scholar
- Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N: Malignant mesothelioma. Intern Med J. 2010, 40: 742-750. 10.1111/j.1445-5994.2010.02223.x.View ArticlePubMedGoogle Scholar
- Loggie BW: Malignant peritoneal mesothelioma. Curr Treat Options Oncol. 2001, 2: 395-399. 10.1007/s11864-001-0044-2.View ArticlePubMedGoogle Scholar
- Taub RN, Keohan ML, Chabot JC, Fountain KS, Plitsas M: Peritoneal mesothelioma. Curr Treat Options Oncol. 2000, 1: 303-312. 10.1007/s11864-000-0046-5.View ArticlePubMedGoogle Scholar
- Levy AD, Shaw JC, Sobin LH: Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009, 29: 347-373. 10.1148/rg.292085189.View ArticlePubMedGoogle Scholar
- Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR: Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009, 133: 1317-1331.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.